Global Drug Repurposing Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Drug Repurposing market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Drug Repurposing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Drug Repurposing market by type, application, key companies and key regions.
This study considers the Drug Repurposing value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Intravenous
Oral
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Cardiovascular Disorders
Central Nervous Disorders
Oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Roche
Abbott Healthcare
Johnson & Johnson
Novartis AG
Teva Pharmaceuticals
Sandoz
Mylan Inc.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Drug Repurposing market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Drug Repurposing market by identifying its various subsegments.
Focuses on the key global Drug Repurposing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drug Repurposing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Drug Repurposing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Repurposing Market Size 2015-2025
2.1.2 Drug Repurposing Market Size CAGR by Region
2.2 Drug Repurposing Segment by Type
2.2.1 Intravenous
2.2.2 Intravenous
2.3 Drug Repurposing Market Size by Type
2.3.1 Global Drug Repurposing Market Size Market Share by Type (2015-2020)
2.3.2 Global Drug Repurposing Market Size Growth Rate by Type (2015-2020)
2.4 Drug Repurposing Segment by Application
2.4.1 Cardiovascular Disorders
2.4.2 Central Nervous Disorders
2.4.3 Oncology
2.4.4 Others
2.5 Drug Repurposing Market Size by Application
2.5.1 Global Drug Repurposing Market Size Market Share by Application (2015-2020)
2.5.2 Global Drug Repurposing Market Size Growth Rate by Application (2015-2020)
3 Global Drug Repurposing by Players
3.1 Global Drug Repurposing Market Size Market Share by Players
3.1.1 Global Drug Repurposing Market Size by Players (2018-2020)
3.1.2 Global Drug Repurposing Market Size Market Share by Players (2018-2020)
3.2 Global Drug Repurposing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Repurposing by Regions
4.1 Drug Repurposing Market Size by Regions
4.2 Americas Drug Repurposing Market Size Growth
4.3 APAC Drug Repurposing Market Size Growth
4.4 Europe Drug Repurposing Market Size Growth
4.5 Middle East & Africa Drug Repurposing Market Size Growth
5 Americas
5.1 Americas Drug Repurposing Market Size by Countries
5.2 Americas Drug Repurposing Market Size by Type
5.3 Americas Drug Repurposing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Drug Repurposing Market Size by Regions
6.2 APAC Drug Repurposing Market Size by Type
6.3 APAC Drug Repurposing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Drug Repurposing by Countries
7.2 Europe Drug Repurposing Market Size by Type
7.3 Europe Drug Repurposing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Drug Repurposing by Countries
8.2 Middle East & Africa Drug Repurposing Market Size by Type
8.3 Middle East & Africa Drug Repurposing Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Drug Repurposing Market Forecast
10.1 Global Drug Repurposing Market Size Forecast (2021-2025)
10.2 Global Drug Repurposing Forecast by Regions
10.2.1 Global Drug Repurposing Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Drug Repurposing Forecast by Type
10.8 Global Drug Repurposing Forecast by Application
11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Drug Repurposing Product Offered
11.1.3 Pfizer Drug Repurposing Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Roche
11.2.1 Company Details
11.2.2 Drug Repurposing Product Offered
11.2.3 Roche Drug Repurposing Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Roche News
11.3 Abbott Healthcare
11.3.1 Company Details
11.3.2 Drug Repurposing Product Offered
11.3.3 Abbott Healthcare Drug Repurposing Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Abbott Healthcare News
11.4 Johnson & Johnson
11.4.1 Company Details
11.4.2 Drug Repurposing Product Offered
11.4.3 Johnson & Johnson Drug Repurposing Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Johnson & Johnson News
11.5 Novartis AG
11.5.1 Company Details
11.5.2 Drug Repurposing Product Offered
11.5.3 Novartis AG Drug Repurposing Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Novartis AG News
11.6 Teva Pharmaceuticals
11.6.1 Company Details
11.6.2 Drug Repurposing Product Offered
11.6.3 Teva Pharmaceuticals Drug Repurposing Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Teva Pharmaceuticals News
11.7 Sandoz
11.7.1 Company Details
11.7.2 Drug Repurposing Product Offered
11.7.3 Sandoz Drug Repurposing Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Sandoz News
11.8 Mylan Inc.
11.8.1 Company Details
11.8.2 Drug Repurposing Product Offered
11.8.3 Mylan Inc. Drug Repurposing Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Mylan Inc. News
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Drug Repurposing Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Intravenous
Table 5. Major Players of Oral
Table 6. Drug Repurposing Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Drug Repurposing Market Size Market Share by Type (2015-2020)
Table 8. Global Drug Repurposing Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Drug Repurposing Market Size Market Share by Application (2015-2020)
Table 10. Global Drug Repurposing Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Drug Repurposing Revenue Market Share by Players (2018-2020)
Table 12. Global Drug Repurposing Key Players Head office and Products Offered
Table 13. Drug Repurposing Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Repurposing Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Drug Repurposing Market Size Market Share by Regions 2015-2020
Table 18. Americas Drug Repurposing Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Drug Repurposing Market Size Market Share by Countries (2015-2020)
Table 20. Americas Drug Repurposing Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Drug Repurposing Market Size Market Share by Type (2015-2020)
Table 22. Americas Drug Repurposing Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Drug Repurposing Market Size Market Share by Application (2015-2020)
Table 24. APAC Drug Repurposing Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Drug Repurposing Market Size Market Share by Regions (2015-2020)
Table 26. APAC Drug Repurposing Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Drug Repurposing Market Size Market Share by Type (2015-2020)
Table 28. APAC Drug Repurposing Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Drug Repurposing Market Size Market Share by Application (2015-2020)
Table 30. Europe Drug Repurposing Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Drug Repurposing Market Size Market Share by Countries (2015-2020)
Table 32. Europe Drug Repurposing Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Drug Repurposing Market Size Market Share by Type (2015-2020)
Table 34. Europe Drug Repurposing Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Drug Repurposing Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Drug Repurposing Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Drug Repurposing Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Drug Repurposing Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Drug Repurposing Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Drug Repurposing Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Drug Repurposing Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Drug Repurposing
Table 43. Key Application and Potential Industries of Drug Repurposing
Table 44. Key Challenges of Drug Repurposing
Table 45. Key Trends of Drug Repurposing
Table 46. Global Drug Repurposing Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Drug Repurposing Market Size Market Share Forecast by Regions
Table 48. Global Drug Repurposing Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Drug Repurposing Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Drug Repurposing Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Drug Repurposing Market Size Market Share Forecast by Application (2021-2025)
Table 52. Pfizer Details, Company Total Revenue (in $ million), Head Office, Drug Repurposing Major Market Areas and Its Competitors
Table 53. Pfizer Drug Repurposing Product Offered
Table 54. Pfizer Drug Repurposing Revenue and Gross Margin (2018-2020E)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Roche Details, Company Total Revenue (in $ million), Head Office, Drug Repurposing Major Market Areas and Its Competitors
Table 58. Roche Drug Repurposing Product Offered
Table 59. Roche Main Business
Table 60. Roche Drug Repurposing Revenue and Gross Margin (2018-2020E)
Table 61. Roche Latest Developments
Table 62. Abbott Healthcare Details, Company Total Revenue (in $ million), Head Office, Drug Repurposing Major Market Areas and Its Competitors
Table 63. Abbott Healthcare Drug Repurposing Product Offered
Table 64. Abbott Healthcare Main Business
Table 65. Abbott Healthcare Drug Repurposing Revenue and Gross Margin (2018-2020E)
Table 66. Abbott Healthcare Latest Developments
Table 67. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Drug Repurposing Major Market Areas and Its Competitors
Table 68. Johnson & Johnson Drug Repurposing Product Offered
Table 69. Johnson & Johnson Main Business
Table 70. Johnson & Johnson Drug Repurposing Revenue and Gross Margin (2018-2020E)
Table 71. Johnson & Johnson Latest Developments
Table 72. Novartis AG Details, Company Total Revenue (in $ million), Head Office, Drug Repurposing Major Market Areas and Its Competitors
Table 73. Novartis AG Drug Repurposing Product Offered
Table 74. Novartis AG Main Business
Table 75. Novartis AG Drug Repurposing Revenue and Gross Margin (2018-2020E)
Table 76. Novartis AG Latest Developments
Table 77. Teva Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Drug Repurposing Major Market Areas and Its Competitors
Table 78. Teva Pharmaceuticals Drug Repurposing Product Offered
Table 79. Teva Pharmaceuticals Main Business
Table 80. Teva Pharmaceuticals Drug Repurposing Revenue and Gross Margin (2018-2020E)
Table 81. Teva Pharmaceuticals Latest Developments
Table 82. Sandoz Details, Company Total Revenue (in $ million), Head Office, Drug Repurposing Major Market Areas and Its Competitors
Table 83. Sandoz Drug Repurposing Product Offered
Table 84. Sandoz Main Business
Table 85. Sandoz Drug Repurposing Revenue and Gross Margin (2018-2020E)
Table 86. Sandoz Latest Developments
Table 87. Mylan Inc. Details, Company Total Revenue (in $ million), Head Office, Drug Repurposing Major Market Areas and Its Competitors
Table 88. Mylan Inc. Drug Repurposing Product Offered
Table 89. Mylan Inc. Main Business
Table 90. Mylan Inc. Drug Repurposing Revenue and Gross Margin (2018-2020E)
Table 91. Mylan Inc. Latest Developments
List of Figures
Figure 1. Drug Repurposing Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Drug Repurposing Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Drug Repurposing Market Size Market Share by Type (2015-2020)
Figure 5. Global Intravenous Market Size Growth Rate
Figure 6. Global Oral Market Size Growth Rate
Figure 7. Drug Repurposing in Cardiovascular Disorders
Figure 8. Global Drug Repurposing Market: Cardiovascular Disorders (2015-2020) ($ Millions)
Figure 9. Drug Repurposing in Central Nervous Disorders
Figure 10. Global Drug Repurposing Market: Central Nervous Disorders (2015-2020) ($ Millions)
Figure 11. Drug Repurposing in Oncology
Figure 12. Global Drug Repurposing Market: Oncology (2015-2020) ($ Millions)
Figure 13. Global Oncology YoY Growth ($ Millions)
Figure 14. Drug Repurposing in Others
Figure 15. Global Drug Repurposing Market: Others (2015-2020) ($ Millions)
Figure 16. Global Others YoY Growth ($ Millions)
Figure 17. Global Drug Repurposing Market Size Market Share by Application in 2019
Figure 18. Global Drug Repurposing Market Size Market Share by Regions 2015-2020
Figure 19. Americas Drug Repurposing Market Size 2015-2020 ($ Millions)
Figure 20. APAC Drug Repurposing Market Size 2015-2020 ($ Millions)
Figure 21. Europe Drug Repurposing Market Size 2015-2020 ($ Millions)
Figure 22. Middle East & Africa Drug Repurposing Market Size 2015-2020 ($ Millions)
Figure 23. Americas Drug Repurposing Market Size Market Share by Countries in 2019
Figure 24. Americas Drug Repurposing Market Size Market Share by Type in 2019
Figure 25. Americas Drug Repurposing Market Size Market Share by Application in 2019
Figure 26. United States Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 27. Canada Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 28. Mexico Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 29. APAC Drug Repurposing Market Size Market Share by Regions in 2019
Figure 30. APAC Drug Repurposing Market Size Market Share by Type in 2019
Figure 31. APAC Drug Repurposing Market Size Market Share by Application in 2019
Figure 32. China Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 33. Japan Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 34. Korea Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 35. Southeast Asia Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 36. India Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 37. Australia Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 38. Europe Drug Repurposing Market Size Market Share by Countries in 2019
Figure 39. Europe Drug Repurposing Market Size Market Share by Type in 2019
Figure 40. Europe Drug Repurposing Market Size Market Share by Application in 2019
Figure 41. Germany Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 42. France Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 43. UK Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 44. Italy Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 45. Russia Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 46. Spain Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 47. Middle East & Africa Drug Repurposing Market Size Market Share by Countries in 2019
Figure 48. Middle East & Africa Drug Repurposing Market Size Market Share by Type in 2019
Figure 49. Middle East & Africa Drug Repurposing Market Size Market Share by Application in 2019
Figure 50. Egypt Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 51. South Africa Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 52. Israel Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 53. Turkey Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 54. GCC Countries Drug Repurposing Market Size Growth 2015-2020 ($ Millions)
Figure 55. Global Drug Repurposing arket Size Forecast (2021-2025) ($ Millions)
Figure 56. Americas Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 57. APAC Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 58. Europe Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 59. Middle East & Africa Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 60. United States Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 61. Canada Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 62. Mexico Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 63. Brazil Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 64. China Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 65. Japan Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 66. Korea Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 67. Southeast Asia Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 68. India Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 69. Australia Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 70. Germany Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 71. France Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 72. UK Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 73. Italy Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 74. Russia Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 75. Spain Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 76. Egypt Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 77. South Africa Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 78. Israel Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 79. Turkey Drug Repurposing Market Size 2021-2025 ($ Millions)
Figure 80. GCC Countries Drug Repurposing Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets